Novavax (NVAX)
(Delayed Data from NSDQ)
$18.17 USD
-1.39 (-7.08%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $18.17 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Novavax, Inc. [NVAX]
Reports for Purchase
Showing records 121 - 140 ( 296 total )
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
NVX-CoV2373 On the Verge of First Approvals and Emergence as Best Booster; Reiterate Buy and $294 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
With NVX-CoV2373, There May Soon Be No Reason to Hesitate; Reiterate Buy and $294 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Near-Term Challenges Deserve Scrutiny but Are Temporary; Reiterate Buy With an Adjusted PT of $294
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for NVAX.
Provider: Stock Traders Daily
Analyst: Research Department